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In the last decade, there is an increasing application of induced pluripotent stem cells
(iPSCs) for disease modeling. The iPSC technology enables the study of patient-specific
neuronal cell lines in vitro to evaluate dysfunction at the cellular level and identify the
responsible genetic factors. This approach might be particularly valuable for filling the
gap of knowledge at the cellular and molecular levels underlying the pathophysiology
of various neurodevelopmental and/or psychiatric disorders, such as attention-deficit
hyperactivity disorder (ADHD). However, the invasiveness of skin biopsy or blood
withdrawal might represent a major impediment in such protected population. Using
hair derived keratinocytes as starting somatic cells circumvents this problem as sample
collections can be performed non-invasively. Here we describe an improved, convenient,
standardized and effective method to culture and reprogram hair derived keratinocytes
from three healthy controls and one ADHD patient into iPSCs, which in turn will be
used to generate differentiated neuronal cells. All the cell types were maintained in
highly defined, serum-free conditions and showed expression of the respective key
marker genes, assessed by both immunocytochemistry and qRT-PCR. The described
in vitro personalized neuronal model has its advantage in modeling neurodevelopmental
trajectories since it can recapitulate key processes of brain development at the cellular
and molecular level and is intended to be used as for example studying ADHD
etiopathology.
Keywords: iPSCs, keratinocyte, hair follicle, reprogramming, ADHD, neurodevelopment, disease modeling, stem
cell
INTRODUCTION
The molecular and cellular mechanisms involved in neurodevelopmental disorders like attention-
deficit hyperactivity disorder (ADHD) are often poorly understood, mainly due to inaccessibility
to brain tissue and limitations of the available model systems.
As it is the case in other neurodevelopmental disorders, investigating the etiopathology of
ADHD at the molecular level is limited by a multitude of factors. Conventional in vitro and in vivo
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model systems lack the patient-specific genetic background
and the complexity of the human brain. With over 70%
heritability, ADHD demonstrates high genetic load (Demontis
et al., 2017); nevertheless, it is postulated to have a polygenetic
character as no high penetrance mutation has yet been associated
(Neale et al., 2010). Genetically modified animal models
have recreated some of the prevailing symptoms of ADHD,
but none of these models managed to reflect the disorder
faithfully enough to lead to significant clinical implication
(Giros et al., 1996; Carvalho et al., 2016). The same applies
to peripheral biological samples, which fail to reveal enough
information about the dysfunction in the central nervous
system, while on the other hand, post-mortem brain tissues
do not give sufficient insights into the abnormal process
occurring during development and are rarely available for
research purposes. Therefore, there is an urgent need to
better understand the pathophysiology of the disorder in
order to develop more effective, practical and individually
tailored pharmaceutical therapies and to discover new predictive
biomarkers.
An interesting candidate for in vitro modeling of
neurodevelopmental disorders is to differentiate patient-
specific induced pluripotent stem cells (iPSCs) into neuronal
lineages. Besides their applications in regenerative medicine
and drug screening (Wu and Hochedlinger, 2011; Trounson
and DeWitt, 2016), iPSCs have proved to be a useful tool in
multitude of diseases such as Schizophrenia, Alzheimer’s and
Parkinson’s disease (Singh et al., 2015). Since its discovery
in 2006 the induced pluripotency technology gained an
enormous interest and applications were established for a
multitude of different research fields (Takahashi and Yamanaka,
2006). The astonishing potential of the iPSC technology
is its ability to generate subject-specific cells, which can
adopt any lineage of choice (Takahashi et al., 2007). iPSCs
differentiation into neuronal cells provides a promising
alternative to ex vivo human neuronal cells, which cannot be
harvested for research purposes for obvious reasons. Moreover,
the differentiation process provides a window into human
neurodevelopment.
Today, most of the reprogramming approaches are still based
on the overexpression of the original factors (i.e., Oct3/4, Klf4,
Sox2, and Myc) which delivery mode has been optimized.
However, new, more convenient, integration-free systems are
immerging, such as RNA vectors or non-integrating viruses
(Raab et al., 2014). Originally, iPSCs were generated from
fibroblast, but over the years protocols have been developed
for the generation of iPSCs from other somatic cells, such as
peripheral blood cells and keratinocytes (Aasen and Belmonte,
2010; Staerk et al., 2010). Like fibroblasts, keratinocytes can
be harvested from a skin biopsy and used for reprogramming
(Ohmine et al., 2012; Piao et al., 2014; Umegaki-Arao et al., 2014;
Nakayama et al., 2018), alternatively foreskin samples (Aasen
et al., 2008), or plucked hair follicle (Aasen and Belmonte,
2010; Petit et al., 2012). Generating iPSCs from keratinocytes
isolated from plucked human hair follicle represents an optimal
choice to study neuropsychiatric disorders (protected population
under ethical laws), as it circumvents the practice of invasive
procedures. Additionally, keratinocytes stem from the same germ
layer as neurons (Robicsek et al., 2013), which might mirror in
a more reliable way abnormalities in neuronal differentiation,
as part of the epigenetic signature may be preserved during
reprograming. Serum-free media has the advantage of reducing
batch to batch variation, providing more defined standardized
conditions that guarantee more reliable downstream experiments
(Brunner et al., 2010). Previously described approaches to
reprogram follicular keratinocytes are based on the integration
of the reprogramming factors into the genome or rely on
the use of feeder layers, which might lead to variations in
downstream experiments (Aasen and Belmonte, 2010; Novak
et al., 2010; Petit et al., 2012; Hung et al., 2015), although
growing the keratinocytes on feeder layer might show higher
reprogramming efficiency (Aasen et al., 2008; Novak et al.,
2010).
Although, several published protocols exist for the iPSCs
generation from keratinocytes, we aimed in this study to
develop a stable and feasible approach to generate subject-specific
neuronal cells by reprogramming follicular keratinocytes. We
chose to prioritize reliability by growing the cells in a serum-
free and feeder-free environment and using a chemically defined
coated surface. The maturation of the generated neuronal cells
can be used as a simplified model of human neurodevelopment,
where direct manipulation can be performed to identify the
involved cellular mechanisms. We aimed to improve the protocol
for the generation of integration-free iPSCs from human hair
follicle for the study of neurodevelopmental disorder. In the
long-term, the described model can be used for example to
compare lines derived from ADHD patients and healthy control
in order to pinpoint the dysregulated pathways that give rise to a
disorder.
METHODS
Subject Recruitment
Recruitment of three control subjects and one male ADHD
patient was performed by a psychiatrist and psychologists
of the Department of Child and Adolescent Psychiatry and
Psychotherapy, University Hospital of Psychiatry Zurich,
University of Zurich. Children and adolescents of both sexes
(control subjects: 2/1 male/females) and of Caucasian descent
between 8 and 16 years of age (mean = 13.75) were recruited. The
diagnosis of ADHD was confirmed according to ICD-10 (World
Health Organization, 1992) and DSM-5 (American Psychiatric
Association, 2013) criteria. IQ screening was performed using
WISC-IV (Wechsler Intelligence test for children; Kaufman
et al., 2006) with an exclusion criteria of IQ < 75. To assess
comorbidities K-SADS-PL (Kiddie Schedule for Affective
Disorders and Schizophrenia, present and lifetime version;
Kaufman et al., 1997), was used. The Family Interview for
Genetic Studies (parents, FIGS; Nurnberger et al., 1994) was
collected to ensure genetic lineage in the subjects. Furthermore,
Conners rating scales (Conners, 2001) and CBCL (Child
Behavior Checklist) questionnaire (Achenbach and Edelbrock,
1991) were collected. In the case of the ADHD patient, the
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adherence to drug treatment was assessed by the Medication
Adherence Report Scale (MARS-D, German edition; Horne
and Hankins, 2004). Exclusion criteria for both healthy controls
and the ADHD patient were predominant neurological or
psychiatric disorders. Healthy controls without any psychiatric
disorder (including no ADHD) were included. Informed written
consent was obtained in all cases from the participants and
their parents. The Study was approved by the Canton Zurich
Ethic Committee (BASEC-Nr.-2016-00101 and BASEC-Nr.-
201700825) and followed the latest version of the Declaration of
Helsinki.
Hair Follicle Collection
To pluck the hair follicle, a firm pull motion with forceps
was performed at the base of the hair. Only plucked hair in
the anagen phase contain enough keratinocytes for a successful
culture initiation. Thus, the hairs should ideally have a big visible
outer root sheath. Generally, the hairs were plucked from the
occipital and temporal scalps regions. The hair shaft was cut
slightly behind the follicle with sterile scissors resulting in an
approximate 5 mm long piece consisting mainly of the follicle.
The plucked hairs were stored in a tube filled with 5 mL
Defined keratinocytes-SFM medium (DKSFM; Gibco – Thermo
Fisher Scientific, Switzerland) at room temperature and were
processed within a few hours after harvesting, although successful
keratinocyte culture was achieved with hair follicles plucked up
to 1 day before and stored in DKSFM at room temperature.
A minimum of five anagen hair follicles was plucked from each
subject.
Isolation and Culture of Keratinocytes
Keratinocyte culture was initiated by following previously
described protocols with modifications (Aasen and Belmonte,
2010; Petit et al., 2012). Hair follicles were incubated for 15 min
at room temperature in an antibiotic solution containing 1X
penicillin and streptomycin (Gibco; i.e., at a final concentration of
100 U/mL penicillin and 100 µg/mL streptomycin). Henceforth,
the samples were handled under aseptic conditions. The tissue
was dissociated into single cell suspension by a two-step
enzymatic digestion with 0.05% Trypsin-EDTA (Gibco) for not
more than 10–15 min each round, as keratinocytes are sensitive
to this treatment and excessive incubation time might cause loss
of cells, followed by inactivation with phosphate-buffered saline
(PBS; Gibco) solution containing 10% fetal bovine serum (FBS;
Gibco). The cells were centrifuged at 200 × g for 5 min and
washed once with 4 mL PBS. After a second centrifugation the
pellet was resuspended in DKSFM containing 0.5X penicillin and
streptomycin. The cells were seeded on a 24-well plate (Sarstedt,
Germany) coated with collagen 1 (“Coating Matrix Kit Protein”;
Gibco) and were placed in a humidified incubator at 37◦C,
5% CO2, and 95% air. After 2 days, the medium was changed
to DKSFM without antibiotics and thereafter, the medium was
replaced every 2–3 days. Sub-confluent (70–90%) cultures were
passaged with 0.05% Trypsin-EDTA and split with a ratio of 1:4
on collagen 1 coated 6-well plate (Sarstedt). Since keratinocytes
can lose their proliferating potential after subsequent passaging,
low passage (P1-P3) cells were used for further applications.
Reprogramming of Follicular
Keratinocytes
Induced pluripotent stem cells were generated using the
CytoTuneTM-iPS 2.0 kit (Invitrogen – Thermo Fisher Scientific,
Switzerland), which is based on three non-integrative Sendai viral
vectors (Thermo Fisher) containing polycistronic Klf4-Oct3/4-
Sox2 (KOS), cMyc, and Klf4, respectively. Three days before the
viral transduction, low passage keratinocytes (Passage 0 or 1)
were seeded on collagen 1 coated 6-well plate at a density of
1× 105 cells/cm2, in order to obtain about 60–70% confluency at
the time of transduction. A multiplicity of infection (MOI) of 3.2-
3.2-2 was used for the three viral vectors, respectively. For each
well to be transfected, the calculated volumes of each of the three
viruses were added to 1 mL DKSFM supplemented with 5 µM
Y-27362 (Adipogen AG, Switzerland), a Rho-associated kinase
ROCK inhibitor, prewarmed to 37◦C and thoroughly mixed.
The medium was removed from the wells and 1 mL of medium
containing the viral vectors was added to each well. The cells
were placed in a humidified incubator at 37◦C 5% CO2. The day
after, the medium was changed to DKSFM supplemented with
5 µM Y-27362 and in the following days was replaced every other
day. Three days after reprogramming, the cells were passaged
with TrypLE (Gibco) and placed on a 6-well plate coated with
vitronectin (Gibco) substrate at a 1:3 splitting ratio. The medium
was progressively switched to Essential 8TM flex (E8, Gibco) with
5 µM Y-27362 8 days after transduction, by increasing the E8
concentration daily to 30, 60, and 100%. From then on, the
medium was changed every day, and the cultures were monitored
for the emergence of colonies with embryonic stem cell-like
morphology. Y-27362 supplementation was discontinued 3 weeks
post-transduction. See Supplementary Figure S1 for an overview
of the reprogramming procedure.
iPSCs Culture
Induced pluripotent stem cells were cultured under serum-free
and feeder layer-free conditions using enzyme-free dissociation
reagents. Colonies were manually isolated starting from
approximately 1 month after reprogramming and fragments
were transferred to a vitronectin coated 24 well plate in E8
medium supplemented with 10 µM Y-27362; each colony
was placed in a separate well. The next day, the medium was
changed with E8 without Y-27362. iPSCs were passaged every
3–4 days using Versene Solution (Gibco) following manufacturer
instructions. All the generated iPSC clones were passaged at
least 10 times to ensure stabilization of the cultures and to
accommodate the cells to the growth conditions. Pluripotency of
the cells was assessed using the live-cell staining with TRA-1-60
Alexa Fluor R© 488 Conjugate Kit (Invitrogen) following the
instructions provided by the manufacturer.
Neural Differentiation of iPSCs
Induced pluripotent stem cells were induced to adopt neural stem
cell (NSC) fate by using “PSC Neural Induction Medium,” which
allows for rapid generation of NSC with mid- and forebrain
identity from iPSCs cultured in monolayer. Passage 12, 80%
confluent, high quality (without visible differentiated cells) iPSC
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culture was passaged at an estimated cell concentration of 3× 105
cells per well of a 6-well plate coated with vitronectin. The
day after passaging, the medium was aspirated and replaced
with 2.5 mL neural induction medium (NIM) composed of
Neurobasal R© Medium (Gibco) supplemented with 1X Neural
Induction Supplement (Gibco) prewarmed at 37◦C. After 2 days
the medium was replaced with fresh NIM prewarmed at 37◦C.
At the next medium change (day 4 and 6 of neural induction)
the cell reached subconfluency and therefore the medium volume
was doubled. After 7 days of culture, the cells reached confluency
and were ready for expansion.
Fully confluent NSC cultures were washed once with PBS
and the cells were dissociated from the surface using StemPro R©
Accutase R© (Gibco) for 5 min at 37◦C. The cells were pelleted by
centrifugations for 4 min at 300× g and resuspended in 4 mL PBS
to dilute the dissociation reagent. Again, the cells were pelleted
and resuspended in 37◦C prewarmed neural expansion medium
(NEM) composed of 50% Neurobasal medium, 50% Advanced
DMEM/F12 (Gibco) and 1X neural induction supplement. Cells
were seeded at 1 × 105 cells/cm2 on a Geltrex (Gibco) coated
6-well plate in 2.5 mL NEM supplemented with 5 µM Y-27632.
The day after, the medium was replaced with 2.5 mL NEM
without Y-27632 and thereafter changed every other day until
the culture was ready to be passaged, usually after 4–5 days.
For the cryopreservation of NSC, the cells were dissociated
using StemPro R© Accutase R©, resuspended in NEM with 10%
DMSO and frozen with a “Mr. Frosty” freezing container.
Thereafter, the cryo-tubes were transferred into liquid nitrogen
tank until use.
Terminal neuronal differentiation was induced by growing
NSCs in neural differentiation medium (NDMC) composed of
Neurobasal R© medium supplemented with 2% B-27 R©(Gibco), 1X
Glutamax (Gibco), 200 µM ascorbic acid (Sigma-Aldrich –
Merck, Switzerland) and 1X CultureOneTM (Gibco) in double
coated Poly-D-Lysine/Laminin (Sigma-Aldrich – Merck) culture
vessels. NSCs at passage 4 were dissociated using StemPro R©
Accutase R©, the pellet was resuspended in 1 mL NDMC and
5 × 104 cells/cm2 were seeded in NDMC supplemented with
5 µM Y-27632. After the cells attached to the surface (usually
after 2–3 h), the medium was carefully changed to NDMC
without the ROCK inhibitor Y-27632 and the plate was returned
to the incubator. The medium was changed every 2–3 days by
removing half of the spent medium and adding the same volume
of prewarmed NDMC carefully toward the wall of the well,
to avoid cell detachment. After 3 weeks of culture, the use of
CultureOneTM supplement was discontinued.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde (PFA; Santa Cruz
Biotechnology, Germany) for 15 min at room temperature. PFA
solution was aspirated and the cells were rinsed three times
with PBS, 5 min per rinse. Blocking buffer, composed of 0.1%
TritonTM X-100 (AppliChem GmbH, Germany) and 1% bovine
serum albumin (Sigma-Aldrich – Merck) in PBS, was added for
30 min at room temperature. Rabbit anti-human- β3 Tubulin
Class III (TUBB3; BioLegend, United States) was added diluted
to a final concentration of 0.5 µg/mL (1:1000) in blocking buffer
and incubated at 4◦C overnight. The cells were rinsed three
times with PBS for 10 min per rinse at room temperature and
the secondary antibody anti-rabbit-Alexa-488 (Invitrogen) in
blocking buffer was added to the cells at a concentration of
1 µg/mL (1:2000) for 30 min. The wells were rinsed twice with
PBS and the slide was mounted with Fluoroshield Mounting
Medium with DAPI (Abcam, United Kingdom). Staining was
visualized under an IX81microscope (Olympus, Switzerland)
with a “DP72” digital camera and the “xcellence RT software”
(Olympus, Version 2.0.1). See Supplementary Material for
antibodies list (Supplementary Table S1).
Quantitative RT-PCR (qRT-PCR)
To extract the RNA, cells were detached, depending on
the cell type, with the dissociation reagent of choice and
the pellet was resuspended in 1 mL RNAprotect (Qiagen,
Germany) and frozen until further use. Total RNA was
extracted using RNeasy Plus Mini kit (Qiagen) according to the
manufacturer’s instructions. RNA concentration and purity were
determined with NanoDrop One spectrophotometer (Thermo
Fisher Scientific). One microgram RNA per sample was reverse
transcribed into cDNA using iScriptTM cDNA Synthesis Kit
(Bio-Rad, Switzerland) on the thermocycler CFX96 R© (Bio-Rad).
Gene expression profile was assessed by qRT-PCR using the
QuantiTect SYBR Green master mix (Qiagen). Primer sequences
were designed with Primer-BLAST (Ye et al., 2012), selected from
PrimerBank (Wang and Seed, 2003) or bought as a commercially
available primer assay kit. See Supplementary Material for
the primers details (Supplementary Table S2). qRT-PCR was
performed using a CFX384TM Real-Time PCR Detection System
(Bio-Rad). Each sample was prepared in triplicates, PCR
efficiency was calculated using LinRegPCR (Ruijter et al., 2009)
and qBasePLUS software (Version 2.3; Biogazelle) was used
to determine the normalized mRNA levels. The expression of
the examined genes (KRT14, MAP2, NES, PAX6, SeV, TERT,
NANOG, OCT3/4, and Lin28A) was normalized to two or three
of the most stably expressed reference genes (HMBS, ACTB, and
GAPDH). The expression of the genes used to assess pluripotency
was compared to the expression in a commercial hiPSC line
(Gibco, catalog number A18945) and isolated RNA from human
embryonic stem cell line (HUES6 cell line). To assess the presence
of Sendai virus in the generated cell line a primer specific to the
viral genome was used. As positive control, SH-SY5Y cells (CRL-
226, ATCC) have been transduced with the Sendai virus and RNA
was isolated 1 day after. The heatmap plot was generated using
the superhot R package.
Karyotyping
It is well known, that long-term culture induces genetic
aberrations in pluripotent cell lines (Liang and Zhang, 2013).
Thus, it is important to regularly assess the quality of the
genetic material in the different cell lines. Briefly, the cells
were treated with 0.1 µg/mL colcemid (Gibco) for 1 h and
subsequently collected by trypsinization. Thereafter, the cells
were incubated in a hypotonic solution (0.4% KCl) for 25 min
at 37◦C, fixed with methanol and glacial acetic acid (3:1 ratio)
three times and stained with Giemsa stain (Gibco) on a glass
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FIGURE 1 | Reprogramming of follicular keratinocytes. (A) Plucked human hair follicle from the scalp region. The hair follicle is in the anagen phase. A visible outer
root sheath (black arrow) is highly visible and intact, thus providing a higher number of keratinocytes. (B) Confluent keratinocyte culture isolated from hair follicles, at
12 days of culture. The cells display typical keratinocyte morphology (strongly adherent cells with cobblestone appearance). (C) Representative Sendai viral
generated iPSC colonies. Passage 1 iPSC culture manually picked from emerging colony in Cytotune 2.0 transfected keratinocytes. The well-defined borders of the
colony are, characteristic of iPSC colonies. (D) The generated iPSC culture stains positively for TRA-1-60 (green), a known pluripotency marker. Nucleus is stained
with NucBlue (blue).
slide (Fisher Scientific). The chromosomes were visualized with
a 100X objective (Zeiss, Germany) using Ikaros Karyotyping
System (MetaSystem, Germany, Version 5.5.5).
Mycoplasma Contamination Assay
Established cell lines were tested for mycoplasma contamination
using the LookOut R© Mycoplasma PCR Detection Kit (Sigma-
Aldrich – Merck) following the manufacturer’s instructions.
PCR was run using a C1000TM/CFX96TM Thermal Cycler and
the amplified products were loaded onto a 1.2% agarose gel
containing HDGreen Plus (INTAS, Germany) diluted 1:20,000
and run at 100 V. Electrophoresis was stopped after 30 min, when
the visible bands migrated ca. 2.5 cm and bands were visualized in
the “Bio-Rad ChemiDocTM XRS+ System” using “Image LabTM”
Software (Bio-Rad, version 5.2.1).
RESULTS
Reprogramming of Hair Derived
Keratinocytes
We managed to efficiently isolate and culture keratinocytes from
a low number of plucked hair follicles in the anagen phase
(Figure 1A). The isolated cells started to form small colonies
of proliferating cells that grew to subconfluency 7–14 days
after culture initiation (Figure 1B). At this point, keratinocytes
were reprogrammed using Sendai viruses containing the
reprogramming factors. During the reprogramming phase,
ROCK inhibitor was supplemented to reduce post-transduction
cell death. At about 3 weeks post-transduction small growing
clumps were visible in the culture and the first colonies were
usually mechanically isolated 1 week after. For each participant
(three healthy controls and one patient with ADHD), two iPSC
clones were selected, expanded and used for further experiments.
The generated iPSC cultures displayed typical embryonic stem
cell morphology (i.e., colony with distinct borders composed
of small cells with prominent nuclei; Figure 1C). TRA-1-
60 staining confirmed the expression of the key pluripotency
marker (Figure 1D). Furthermore, gene expression analysis
revealed an upregulated expression of telomerase reverse
transcriptase (TERT), NANOG, octamer-binding transcription
factor 3/4 (OCT3/4), lin-28 homolog A (LIN28A) and a
downregulation of the keratinocyte marker keratin 14 (KRT14),
compared to keratinocyte cultures (Figure 2 and Supplementary
Table S3 for detailed relative expression). Overall, both the
morphology (Figure 1 and Supplementary Figure S2) and the
gene expression profiles of the generated iPSC colonies were
comparable to the commercial iPSC (Figure 2). Moreover, the
gene expression of the generated iPSCs was comparable to the
RNA from the hESC HUES6 line (Figure 2).
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FIGURE 2 | Heatmap showing the qRT-PCR result for the pluripotency markers LIN28A, NANOG, OCT3/4, and TERT and the keratinocyte marker KRT14. Upon
reprogramming the keratinocyte marker KRT14 is highly downregulated, while markers for pluripotency are upregulated in all the generated iPSC lines. For the tested
genes, the generated lines show similar expression pattern as the commercial hiPSC line and the embryonic stem cell line. Samples were analyzed in triplicates,
normalized to the most stable reference genes (ACTB, HMBS, and GAPDH). Values were log2 transformed and the plot was generated with the R package
superheat (see Supplementary Table S3). Levels of high expression are shown with red, while levels of low expression are shown with green. K, control; MR,
methylphenidate responder ADHD patient.
Passage 10 iPSC cultures were tested for mycoplasma
contamination. The absence of a band in the 260 bp range
in the electrophoresis gel indicates that the tested samples
are not contaminated by mycoplasma (Supplementary Figure
S3). To assess the absences of the viral vectors used for the
reprogramming we performed qRT-PCR in passage 10 iPSC lines
using a Sendai specific primer. As a positive control RNA was
isolated from SH-SY5Y neuroblastoma cell line transduced with
Sendai virus containing hKlf4 at an MOI = 6 three days before
harvesting the cells and reversed transcribed to cDNA. For a
negative control, untransfected SH-SY5Y cells were used. The
analysis showed that one of the eight generated lines were virus-
free, while the remaining seven lines showed minimal viral RNA
traces (Figure 3). G-banding analysis showed that the tested lines
have a normal karyotype (Figure 4).
Neuronal Differentiation
Induced pluripotent stem cells were forced to adapt neural
precursor cell fate by using NIM, a commercially available
differentiation medium, on Geltrex R© coated surface. Within
7 days, the cells showed changes in the morphology, switching
from a rather uniform cell distribution in the colony distinctive of
iPSC cultures to colonies with tangential polarity (Figure 5A). At
passage 4 NSCs showed a homogenous morphology (Figure 5B)
and were differentiated into neuronal cells by plating them on
Poly-D-Lysine/Laminin double coated surface and by providing
neural induction factors in NDM. Already the day after plating,
the cells displayed production of short projections outgrowth
from the cell body. On day 4 of differentiation, long neurites
were clearly visible (Figure 5C). A complex network was formed
by day 24 of differentiation and to the cells stained positively
for TUBB3, a commonly used neuronal marker (Figure 5D).
Immunocytochemistry with GFAP antibody showed no positive
cells in the culture, indicating that no astrocytes were present
(data not shown). Gene expression analysis indicates that NSCs
express nestin (NES) and paired box 6 (PAX6), both markers of
neural precursor cells, while During terminal differentiation the
cell show expression of microtubule associated protein 2 (MAP2,
Figure 6).
DISCUSSION
Keratinocytes were successfully isolated and cultured in serum-
free media using the described method. We showed that iPSCs
can be generated from plucked hair follicles in highly defined
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FIGURE 3 | Assessment of Sendai virus traces using qRT-PCR in the cell lines
at passage 10. The generated lines show no or little presence of the virus
used for reprogramming. Samples were analyzed in triplicates, normalized to
the most stable reference genes (ACTB, HMBS, and GAPDH). Values are
given as mean ± SEM.
cell culture conditions using non-integrative reprogramming
vectors. Isolated pluripotent colonies were as well cultured in
serum-free media. The described method is an improvement
over previously described protocols for the reprogramming of
keratinocytes in that we combine using an easily accessible
cell source, the use of a non-integrative reprogramming
approach and circumvent the use of feeder layers and serum
containing medium during the reprogramming (see comparison
of published protocols in Table 1). We could show that
this method is feasible also in generating iPSC from young
ADHD patient, though further samples are required to conduct
comparison studies with controls at the molecular and cellular
levels. Keratinocytes from hair follicle are an excellent choice
for sample collection from patients, however, these cells can
be rather difficult to maintain in vitro when compared to
other primary human cells such as fibroblasts by showing
less attachment at culture derivation, tendency to differentiate
and limited growth potential (Freshney, 2000; Strudwick et al.,
2015). We therefore suggest using low passage keratinocytes
for the reprogramming experiment. Trypsinization of the hair
follicles has proven to be a critical step for the success of
the culture initiation. Therefore, short incubation time with
low concentrated Trypsin at room temperature was used for
the dissociation of the hair follicle and the passaging of
keratinocytes. In addition, it is critical that a sufficient number
of hair follicles in the anagen phase and with a visible outer
root sheath (the tissue layer where the proliferation capable
keratinocytes are found) are used. Extensive cell death has
been observed when keratinocytes grown in serum/feeder-free
conditions are reprogrammed (Aasen and Belmonte, 2010).
We found that ROCK inhibitor supplementation improved
FIGURE 4 | A representative G-banding analysis of a Passage 10 iPSC line. The analyzed clone was karyotypically normal (46, XY), showing no gross genetic
aberration.
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FIGURE 5 | Neuronal differentiation. (A) Day 7 of neural induction, the iPSC morphology is lost and the culture is ready to be harvested and expanded. (B) Passage
4 NSC culture. (C) At day 4 of terminal neuronal differentiation the cells begin to form a neuronal network. (D) Tubulin beta 3 class III (green) staining of neuronal cells
at day 24 of terminal neuronal differentiation. Counter staining of the nucleus was conducted by DAPI staining (blue).
the post-transduction cell death. It was previously shown
that cMyc overexpression induces apoptosis in keratinocytes
and the effect can be ameliorated with Y-27632 addition
after the transduction (Dakic et al., 2016). The presented
method was successful in generating iPSC lines that express
pluripotency markers (TRA-1-60, TERT, NANOG, OCT3/4,
and LIN28A) while KRT14 expression is strongly reduced,
similar to the expression profile of embryonic stem cells and
the commercial iPSC line. Next, the iPSCs were forced to
adopt neuronal lineage using a fast and feasible approach
for neuronal differentiation and providing adequate factors.
Depending on the application, other neuronal differentiation
approaches can be adopted. For example, dopaminergic or
glutamatergic differentiation can be induced (Robicsek et al.,
2013). If higher complexity is desired, protocols have been
described to generate more complex neuronal cultures such
as astrocyte-neurons co-cultures (Kuijlaars et al., 2016), or 3D
brain organoids (Mariani et al., 2012); these approaches are,
however, usually less reproducible and take a longer time to
achieve.
CONCLUSION
In conclusion, we describe a standardized and relatively simple
approach to generate participants-specific neuronal cultures
by reprogramming easily accessible somatic cells, namely hair
FIGURE 6 | Gene expression results of neuronal differentiation. Samples were
assessed for the expression of PAX6, NES, and MAP2 and normalized to
ACTB and GAPDH as the most stable reference genes. Neural progenitor
makers PAX6 and NES are upregulated in passage 4 NSCs (N = 8), while
neuronal marker MAP2 is upregulated in neuronal cells at day 28 of neuronal
differentiation (N = 2). Values are given as mean ± SEM.
derived keratinocytes. The protocol is intended to be used
as a model to study early neurodevelopment by evaluating
the differentiation dynamics of the iPSC derived neurons
at the molecular level. It is therefore particularly promising
for the study of the etiopathology of ADHD and other
neurodevelopmental disorders.
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